Literature DB >> 32934971

An association between mitochondria and microglia effector function. What do we think we know?

G Jean Harry1, Gabrielle Childers1,2, Sahana Giridharan1,3, Irisyunuel Lopez Hernandes1.   

Abstract

While resident innate immune cells of the central nervous system, the microglia, represent a cell population unique in origin, microenvironment, and longevity, they assume many properties displayed by peripheral macrophages. One prominent shared property is the ability to undergo a metabolic switch towards glycolysis and away from oxidative phosphorylation (OXPHOS) upon activation by the pro-inflammatory stimuli lipopolysaccharide. This shift serves to meet specific cellular demands and allows for cell survival, similar to the Warburg effect demonstrated in cancer cells. In contrast, normal survelliance phenotype or stimulation to a non-proinflammatory phenotype relies primarily on OXPHOS and fatty acid oxidation. Thus, mitochondria appear to function as a pivotal signaling platform linking energy metabolism and macrophage polarization upon activation. These unique shifts in cell bioenergetics in response to different stimuli are essential for proper effector responses at sites of infection, inflammation, or injury. Here we present a summary of recent developments as to how these dynamics characterized in peripheral macrophages are displayed in microglia. The new insights provided by an increased understanding of metabolic reprogramming in macrophages may allow for translation to the CNS and a better understanding of microglia heterogeneity, regulation, and function.

Entities:  

Keywords:  anti-inflammatory; inflammasome; microglia; mitochondria bioenergetics; polarization; pro-inflammatory

Year:  2020        PMID: 32934971      PMCID: PMC7489447          DOI: 10.20517/2347-8659.2020.07

Source DB:  PubMed          Journal:  Neuroimmunol Neuroinflamm        ISSN: 2347-8659


  202 in total

Review 1.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 2.  Microglial M1/M2 polarization and metabolic states.

Authors:  Ruben Orihuela; Christopher A McPherson; Gaylia Jean Harry
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

3.  Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages.

Authors:  Oleg Lunov; Tatiana Syrovets; Cornelia Loos; G Ulrich Nienhaus; Volker Mailänder; Katharina Landfester; Mustapha Rouis; Thomas Simmet
Journal:  ACS Nano       Date:  2011-12-08       Impact factor: 15.881

4.  Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway.

Authors:  Jingkao Chen; Zhaowei Sun; Minghua Jin; Yalin Tu; Shengnan Wang; Xiaohong Yang; Qiuhe Chen; Xiao Zhang; Yifan Han; Rongbiao Pi
Journal:  J Neuroimmunol       Date:  2017-02-08       Impact factor: 3.478

5.  The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.

Authors:  Vandana Deora; John D Lee; Eduardo A Albornoz; Luke McAlary; Cyril J Jagaraj; Avril A B Robertson; Julie D Atkin; Matthew A Cooper; Kate Schroder; Justin J Yerbury; Richard Gordon; Trent M Woodruff
Journal:  Glia       Date:  2019-10-09       Impact factor: 7.452

Review 6.  Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Authors:  Peter J Murray
Journal:  Curr Opin Pharmacol       Date:  2006-05-18       Impact factor: 5.547

7.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

8.  Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Authors:  Gaia Codolo; Nicoletta Plotegher; Tommaso Pozzobon; Marco Brucale; Isabella Tessari; Luigi Bubacco; Marina de Bernard
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 9.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

10.  New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.

Authors:  Zhenyu Zhong; Shuang Liang; Elsa Sanchez-Lopez; Feng He; Shabnam Shalapour; Xue-Jia Lin; Jerry Wong; Siyuan Ding; Ekihiro Seki; Bernd Schnabl; Andrea L Hevener; Harry B Greenberg; Tatiana Kisseleva; Michael Karin
Journal:  Nature       Date:  2018-07-25       Impact factor: 49.962

View more
  7 in total

Review 1.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

2.  Brain Transcriptome Responses to Dexamethasone Depending on Dose and Sex Reveal Factors Contributing to Sex-Specific Vulnerability to Stress-Induced Disorders.

Authors:  Eduard Murani; Nares Trakooljul; Frieder Hadlich; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Neuroendocrinology       Date:  2021-04-14       Impact factor: 4.914

Review 3.  Microglia as therapeutic targets after neurological injury: strategy for cell therapy.

Authors:  M Collins Scott; Supinder S Bedi; Scott D Olson; Candice M Sears; Charles S Cox
Journal:  Expert Opin Ther Targets       Date:  2021-06-01       Impact factor: 6.902

4.  Oxidant therapy improves adipogenic differentiation of adipose-derived stem cells in human wound healing.

Authors:  Christian Ploner; Tina Rauchenwald; Catherine E Connolly; Karin Joehrer; Johannes Rainer; Christof Seifarth; Martin Hermann; Markus Nagl; Susanne Lobenwein; Doris Wilflingseder; Giuseppe Cappellano; Evi M Morandi; Gerhard Pierer
Journal:  Stem Cell Res Ther       Date:  2021-05-10       Impact factor: 6.832

5.  Investigations into the Role of Metabolism in the Inflammatory Response of BV2 Microglial Cells.

Authors:  Pamela Maher
Journal:  Antioxidants (Basel)       Date:  2021-01-14

6.  An Inhibitor of NF-κB and an Agonist of AMPK: Network Prediction and Multi-Omics Integration to Derive Signaling Pathways for Acteoside Against Alzheimer's Disease.

Authors:  Ying-Qi Li; Yi Chen; Si-Qi Jiang; Yuan-Yuan Shi; Xiao-Li Jiang; Shan-Shan Wu; Ping Zhou; Hui-Ying Wang; Ping Li; Fei Li
Journal:  Front Cell Dev Biol       Date:  2021-07-19

Review 7.  Energy Metabolism Decline in the Aging Brain-Pathogenesis of Neurodegenerative Disorders.

Authors:  Janusz Wiesław Błaszczyk
Journal:  Metabolites       Date:  2020-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.